NS PHARMA

Pharmaceutical preparations for the treatment of myelofibrosis; pharmaceutical preparations for the treatment of eosinophilic granulomatosis with polyangiitis; pharmaceutical preparations for the treatment of endometriosis; pharmaceutical preparations for the treatment of retinal dystrophies; pharmaceutical preparations for the treatment of Leber congenital amaurosis; pharmaceutical preparations for the treatment of cardiomyopathy; pharmaceutical preparations for the treatment of muscular dystrophy; pharmaceutical preparations for the treatment of Mucopolysaccharidosis; pharmaceutical preparations for the treatment of Lysosomal disease